Skip to main content

Table 3 The summary of echocardiographic examination results of patients divided into CKD stage groups

From: Markers of increased atherosclerotic risk in patients with chronic kidney disease: a preliminary study

Table 3.

Stage I/II

Stage III

Stage IV

Stage V

p

N=20

N=20

N=20

N=20

E/A

0.8 (0.8-1.1)

0.8 (0.7-0.95)

0.9 (0.8-1.2)

0.9 (0.8-1.3)

NS

E/E’

7.4±2.0

8.1±3.9

7.1±3.5

13.6±4.41,3,6

P=0.001

Diastolic dysfunction [%]

81.8

93.3

100.0

94.7

NS

Contractility disorders [%]

33.3

42.9

36.4

78.91,5

P=0.040

Mitral valve fibrosis [%]

81.8

80.0

70.6

90.5

NS

Aortic valve fibrosis [%]

9.1

20.0

23.5

4.8

NS

Mitral valve calcifications [%]

0

0

17.6

28.61

P=0.044

Aortic valve calcifications [%]

0

13.3

23.5

61.92,5

P=0.0008

IM [%]

54.5

50.0

58.8

81.0

NS

IA [%]

10.0

12.5

0

4.8

NS

IT [%]

27.3

25.0

37.5

71.41

P=0.016

  1. 1 p<0.05; 2 p<0.01 vs Stage I; 3 p<0.05; 4 p<0.01 vs Stage III; 5 P<0.05; 6 p<0.01 vs Stage IV